Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 55 (16) , 1743-1750
- https://doi.org/10.1016/j.jacc.2010.02.008
Abstract
No abstract availableKeywords
Funding Information
- Korean Society of Interventional Cardiology
This publication has 20 references indexed in Scilit:
- Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcationsAmerican Heart Journal, 2008
- Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting StentsJournal of the American College of Cardiology, 2007
- Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary PracticeJournal of the American College of Cardiology, 2007
- Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stentsAmerican Heart Journal, 2007
- Sirolimus- vs Paclitaxel-Eluting Stents in De Novo Coronary Artery LesionsJAMA, 2006
- Una clasificación simple de las lesiones coronarias en bifurcaciónRevista Espanola de Cardiologia, 2006
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic PatientsNew England Journal of Medicine, 2005
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003